Page last updated: 2024-08-23

nigericin and 2-((aminocarbonyl)amino)-5-(4-fluorophenyl)-3-thiophenecarboxamide

nigericin has been researched along with 2-((aminocarbonyl)amino)-5-(4-fluorophenyl)-3-thiophenecarboxamide in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Bodendorf, U; Boettcher, A; Bornancin, F; Eder, J; Erbel, P; Farady, CJ; Fruhauf, A; Heiser, D; Kauffmann, M; Rubert, J; Schlapbach, A; Unterreiner, A1

Other Studies

1 other study(ies) available for nigericin and 2-((aminocarbonyl)amino)-5-(4-fluorophenyl)-3-thiophenecarboxamide

ArticleYear
Pharmacological inhibition of IKKβ dampens NLRP3 inflammasome activation after priming in the human myeloid cell line THP-1.
    Biochemical and biophysical research communications, 2021, 03-19, Volume: 545

    Topics: Amides; Caspase 1; Humans; I-kappa B Kinase; Immunity, Innate; Inflammasomes; Interleukin-1beta; NF-kappa B; Nigericin; NLR Family, Pyrin Domain-Containing 3 Protein; Protein Kinase Inhibitors; Thiophenes; THP-1 Cells

2021